Clinical trial
Treatment of Newly Diagnosed Elderly Patients With Multiple Myeloma
NCT00367185 · University Hospital, Lille, Other · Completed
Key facts
| NCT number | NCT00367185 |
|---|---|
| Title | Treatment of Newly Diagnosed Elderly Patients With Multiple Myeloma |
| Official title | Comparison of Melphalan-Prednisone(MP),MP-THALIDOMIDE,and Autologous Stem Cell Transplantation in the Treatment of Newly Diagnosed Elderly Patients With Multiple Myeloma. |
| Lead sponsor | University Hospital, Lille, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Multiple Myeloma |
| Intervention type | Drug |
| Interventions | Thalidomide |
| Enrollment | 500 |
| Start date | May 1, 2000 |
| Completion | Oct 1, 2005 |
| First posted | Aug 22, 2006 |
| Last update posted | Aug 22, 2006 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: